Low vaccination rates for influenza viruses and the lack of an HSV vaccine underscore the need for a new approach to reduce viral transmission. Researchers have now used a clinical-grade antiviral ...

A chewing gum made from lablab beans may be the next big tool in fighting viral transmission. Scientists found that this gum ...

The incidence of neonatal herpes simplex virus (nHSV) infections in the United States in 2019 was 15.7 per 100,000 hospital ...

Looking beyond jabs, sprays or tablets, scientists are thinking outside the box for delivering antiviral medication to ...

Genital herpes simplex virus (HSV) infections are frequently asymptomatic or undiagnosed, but more than half the US population is seropositive for HSV, and about one-fifth are positive for HSV-2.

Ruvidar(TM) demonstrates higher efficacy in the treatment of Herpes Simplex Virus, Type 1 versus the standard of care treatments Acyclovir and Abreva in a preclinical animal model. Herpes Simplex ...

A significant association was observed between HSV-2 infection and the occurrence of high-risk HPV, particularly the primary types attributed to cervical cancer.

Assembly Biosciences (ASMB) announced data from its herpes simplex virus program featured in three poster presentations at the 2025 Congress of ...

Learn how antiviral chewing gum made from lablab beans may help reduce virus transmission with exciting clinical trials ahead ...

The virus is herpes simplex one. “Virus, per se, is a quiet virus. It just quietly likes to live in our neurons,” Shukla said. Herpes hides in the trigeminal nerves that stretch to the eyes ...